by Oncospherix | Oct 22, 2022 | General
The Agile Falcon Drug Discovery Strategic Summit will be held at the Grand Hyatt at the San Francisco Airport on October 27-28, 2022. OncoSpherix’s CEO, Dr. Margaret Offermann, will be presenting a keynote address entitled “Overcoming Past Challenges in...
by Oncospherix | Jun 4, 2022 | General
The Global Women in STEM Leadership Summit is designed to inspire attendees through sessions tailored specifically for promoting women in STEM. It brings together influential leaders and founders from industry, academia, nonprofit and government to share their...
by Oncospherix | May 23, 2022 | General
OncoSpherix is pleased to announce that Thomas Saylor has joined the company’s business advisory board. Mr. Saylor has served as CEO of six emerging biotech companies in the U.S., Europe and Asia, leading enterprises that cover drug development, pharmaceutical...
by Oncospherix | May 5, 2022 | General
OncoSpherix is pleased to announce that Dr. Harvey Golomb has joined the Clinical Advisory Board of OncoSpherix. Dr. Golomb’s recognition as a preeminent leader in oncology began early in his career, as reflected by his election in 1990 as President of the American...
by Oncospherix | Apr 20, 2022 | General
Dr. Erwin Van Meir is the inaugural David Hart White Endowed Professorship for Brain Cancer Research at the National Cancer Institute-designated O’Neal Comprehensive Cancer Center at the University of Alabama Birmingham. Dr. Van Meir’s research illuminates how genetic...
